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CIRCULAR DICHROISM EXPERIMENT 
Results 
Experimental CD curves and calculated ECD spectra for all compounds are shown on Figure S1. In any case, 
the experimental curves show several positive and negative Cotton effects (CE). Strong maxima or minima 
occur at about 490, 265, and 220 nm for 1-acetoxycryptotanshinone; 500, 355, 270, 250, and 220 nm for 
acetoxytanshinone IIA; 370, 340, 295, and 220 nm for 1-oxoaegyptinone A; as well as 330, 285, 260, and 220 nm 
for isograndifoliol. These effects resulted from the π → π∗ transition in the aromatic part of studied 
compounds. The calculated spectra show patterns similar to those of the experimental spectra. Some 
differences may correspond to the differences in real conforming structure. However, based on these results, it 
can be concluded that the configuration of the studied compounds is as proposed based on NMR spectra 
analysis. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Supplementary  Figure  1. Comparison  of  experimental  and  calculated  CD  spectra: A–1-(acetyloxy)- 
cryptotanshinone,  B–acetoxytanshinone  IIA,  C–3,10,11-trimethyl-2,3,9,10-tetrahydroanthra[1,2,b]furan- 
4,5,7(8H)-trion, and D–isograndifoliol.
Experimental conditions 
Circular dichroism 
Circular dichroism spectra of all analyzed compounds were made in room temperature on a Jasco J-1500 
magnetic circular dichroism spectrometer (JASCO, Japan).  1 mm pathlength was used. CD spectra were 
collected at a scan rate speed of 100 nm min-1 with response time of 1 s. Measurements were made in the range 
of 200–600 nm. All spectra were baseline corrected and the final plot was taken from three accumulated plots. 
The concentrations of compounds were from 0.25 mg/ml to 1.1 mg/ml. 
Computational Methods 
Calculations were performed using the Gaussian 2016 A.03 software package [1]. Conformation analysis of all 
compounds was performed using Monte Carlo. Conformers within a 2 Kcal/mol energy difference from the 
global minimum were selected for structure and electronic properties calculations. The ground state geometric 
optimizations were calculated using density functional theory (DFT) with Becke’s three-parameter hybrid 
exchange function with the Lee–Yang–Parr gradient 
corrected correlation (B3LYP) [2–4] functional in combination with 6–311+G (d,p) basis set. Harmonic 
vibrational wavenumbers were calculated using analytic second derivatives to confirm the convergence to 
minima in the potential surface. The electronic properties, such as excitation energy and rotatory strengths, 
were calculated using time-dependent density functional theory at the TDDFT/6– 311+G (d, p) level.  The 
hybrid functionals PBE0 [5] were employed in calculations. TDDFT 
calculations also included solvent effect [6,7]. ECD curves were obtained on the basis of rotator strengths with 
a half-band of 0.25 eV using SpecDis v1.71 [8]. 
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 NMR SPECTRA OF ISOLATED COMPOUNDS 
 
 
1H (500 MHz) NMR spectrum of compound 1in CD3OD, 25°C 
13C (125 MHz)  NMR  spectrum of compound  1 in CD3OD, 25°C 
 
1H-1H COSY NMR spectrum of compound 1 in CD3OD, 25°C 
 
1H-1H ROESY NMR spectrum of compound 1 in CD3OD, 25°C 
1H-13C H2BC NMR spectrum of compound 1 in CD3OD, 25°C  
 
1H-13C HSQC NMR spectrum of compound 1 in CD3OD, 25°C 
 
1H-13C HMBC 3 Hz NMR spectrum of compound 1 in CD3OD, 25°C  
 
1H-13C HMBC 8 Hz NMR spectrum of compound 1 in CD3OD, 25°C 
 
  
1H (500 MHz) NMR spectrum of compound 2 in CD3OD, 25°C 
 
 
13C (125 MHz) NMR spectrum of compound 2 in CD3OD, 25°C 
  
1H-1H COSY NMR spectrum of compound 2 in CD3OD, 25°C 
 
 
1H-1H TROESY NMR spectrum of compound 2 in CD3OD, 25°C 
1H-13C H2BC NMR spectrum of compound 2 in CD3OD, 25°C  
 
1H-13C HSQC NMR spectrum of compound 2 in CD3OD, 25°C 
 
1H selective-TOCSY spectrum at 6.41 ppm of compound 2 in CD3OD, 25°C  
 
1H-13C HMBC 8 Hz NMR spectrum of compound 2 in CD3OD, 25°C 
 
  
1H (500 MHz) NMR spectrum of compound 3 in CD3OD, 25°C 
 
 
13C (125 MHz) NMR spectrum of compound 3 in CD3OD, 25°C 
  
1H-1H COSY NMR spectrum of compound 3 in CD3OD, 25°C 
 
 
1H-1H TROESY NMR spectrum of compound 3 in CD3OD, 25°C 
1H-13C H2BC NMR spectrum of compound 3 in CD3OD, 25°C  
 
1H-13C HSQC NMR spectrum of compound 3 in CD3OD, 25°C 
 
1H-13C HMBC 3 Hz NMR spectrum of compound 3 in CD3OD, 25°C  
 
1H-13C HMBC 8 Hz NMR spectrum of compound 3 in CD3OD, 25°C 
 
  
1H selective-TOCSY spectrum at 5.01 ppm of compound 3 in CD3OD, 25°C 
 
